Akihiko Kawahara

Toho University — Japan

Medicine · Health Sciences

41h-index6.6kcitations406works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(94), Lung Cancer Treatments and Mutations(67), Immunotherapy and Immune Responses(59), Pancreatic and Hepatic Oncology Research(42), Salivary Gland Tumors Diagnosis and Treatment(40)

Publications405 total

A Case of Heterotopic Pregnancy Resulting in a Live Birth Through Laparoscopic Surgery
Cureus·2025Open Access
Comprehensive genetic profiling using tissue and blood in locally advanced tumors
Oncology Reports·2025Open Access
Comparison of Comprehensive Genomic Profiling Testing “Ion Torrent Genexus Sequencer” With FoundationOne
Anticancer Research·2025Open Access
Exploration of plasma factor profiles involved in tumor growth factors in non-small cell carcinoma patients with interstitial pneumonia
Respiratory Investigation·2025
Impact of Cold Ischemic Time on Nucleic Acid Quality in Cytology Samples for Cancer Gene Analysis
Cytopathology·2025
Diagnostic Criteria of Bile Cytology: A Multicenter Comparative Study of Conventional and Liquid-Based Cytology in Japan
Acta Cytologica·2025Open Access
The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-Small Cell Lung Cancer
Chemotherapy·2025
Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy
Cancer Immunology Immunotherapy·2024· 8 citedOpen Access
Identification of DNA Repair-related Genes as Biomarkers Reflecting MSI, TMB, and TIL in Colorectal Cancer
Anticancer Research·2024· 4 cited
Upregulated Nuclear Y-box Binding Protein-1 Expression is Closely Associated with Mammalian Target of Rapamycin Expression in Endometrial Cancer
The Kurume Medical Journal·2024Open Access
Advances in diagnostic liquid‐based cytology
Cytopathology·2024· 7 cited
Characterization of Pre- and Post-treatment Soluble Immune Mediators and the Tumor Microenvironment in NSCLC Patients Receiving PD-1/L1 Inhibitor Monotherapy
2024Open Access
Comparison of Comprehensive Genomic Profiling Testing “Ion Torrent Genexus Sequencer” with FoundationOne
Research Square (Research Square)·2024Open Access
Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma
Oncology Letters·2024· 2 citedOpen Access
Learning salivary gland cytology from the basics
The Journal of the Japanese Society of Clinical Cytology·2024Open Access
Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors
Cancer Medicine·2023· 14 citedOpen Access
Case Report: A case of complete response to entrectinib in NTRK fusion gene-positive parotid gland cancer
Frontiers in Oncology·2023· 7 citedOpen Access
Enhanced nuclear Y-box binding protein-1 expression predicts poor prognosis in close association with mammalian target of rapamycin expression in endometrial cancer
Research Square (Research Square)·2023Open Access
Lymph node metastatic status could predict the prognosis of intracholecystic papillary neoplasm of gallbladder
Human Pathology·2023· 1 cited
Prognostic effect of cachexia in patients with non‐small cell lung cancer receiving immune checkpoint inhibitors
Thoracic Cancer·2023· 20 citedOpen Access
page 1 of 21Next →

Frequent Co-authors

Masayoshi Kage(31), Koichi Azuma(25), Satoshi Hattori(18), Michihiko Kuwano(17), Tomoaki Hoshino(16), Mayumi Ono(16), Jun Akiba(12), Kosuke Watari(9), Yûichi Murakami(9), Tetsuro Sasada(9), Hiroto Izumi(8), Yoshito Akagi(8), Hideyuki Abe(8), Hidenobu Ishii(7), Kazuhiko Yamada(7), Shinzo Takamori(6), Takaaki Tokito(6), Takashi Kinoshita(6), Kazutaka Nakashima(6), Tomohiko Yamaguchi(6)